scispace - formally typeset
B

Bahram Kazemi

Researcher at Shahid Beheshti University of Medical Sciences and Health Services

Publications -  414
Citations -  4986

Bahram Kazemi is an academic researcher from Shahid Beheshti University of Medical Sciences and Health Services. The author has contributed to research in topics: Gene & Recombinant DNA. The author has an hindex of 34, co-authored 395 publications receiving 4333 citations. Previous affiliations of Bahram Kazemi include University of Kashan & Shiraz University.

Papers
More filters
Journal ArticleDOI

Effects of low-level He-Ne laser irradiation on the gene expression of IL-1beta, TNF-alpha, IFN-gamma, TGF-beta, bFGF, and PDGF in rat's gingiva.

TL;DR: It is suggested that low-level He–Ne laser irradiation decreases the amount of inflammation and accelerates the wound healing process by changing the expression of genes responsible for the production of inflammatory cytokines.
Journal ArticleDOI

Genetic variability of Blastocystis sp. isolated from symptomatic and asymptomatic individuals in Iran.

TL;DR: In this study, ST1 in gastrointestinal patients compared to asymptomatic individuals was significantly dominant and significantly related to GI symptoms, and eight mixed infections with three different STs, which are under reported, were also identified.
Journal ArticleDOI

Nano-based antileishmanial agents: a toxicological study on nanoparticles for future treatment of cutaneous leishmaniasis

TL;DR: In spite of antileishmanial activity of nanoparticles under UV, IR, and dark conditions, these nanoparticles had high cytotoxicity on macrophages, which must be considered in future studies.
Journal ArticleDOI

Canine visceral leishmaniasis: asymptomatic infected dogs as a source of L. infantum infection.

TL;DR: Asymptomatic infected dogs as well as symptomatic ones can harbor L. infantum in their blood and skins which are virulent and infectious for inoculated golden hamster.
Journal ArticleDOI

In vivo drug delivery of gemcitabine with PEGylated single-walled carbon nanotubes.

TL;DR: The results demonstrate that the new formulation of GEM is useful strategy for improving the antitumor efficacy of Gemcitabine and afford higher efficacy in suppressing tumor growth than SWCNT-GEM and GEM in B6 nude mice.